New trial data suggest dietary fiber supplementation may lower systolic blood pressure in adults with type 2 diabetes and hypertension.
Read More »Type 2 Diabetes Damages the Pancreas, Or Does It?
New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.
Read More »Can Psychotherapy Lower Blood Sugar? New Evidence Finds a Link Between Mind and Metabolism
Discover how psychotherapy for type 2 diabetes may improve A1C, support self-management, and influence weight and metabolic health.
Read More »Can Resistant Starch Lower Your Next Blood Sugar Spike? Inside the “Second-Meal Effect”
Could the carbohydrates eaten at breakfast affect the blood sugar response to lunch? Research on resistant starch and the second-meal effect suggests they might. Resistant starch escapes much of the digestion that normally occurs in the small intestine. As a result, less of it is immediately converted to glucose, while …
Read More »Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?
Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …
Read More »GLP-1s and Opioids: The GI Risk Clinicians May Be Missing
GLP-1 receptor agonists have transformed the treatment of type 2 diabetes, but their effects on gastrointestinal motility remain an important clinical consideration. Opioids can also slow gastrointestinal function, raising an obvious question: what happens when patients need both? New research examining GLP-1 and opioid interactions suggests that opioid choice may …
Read More »Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?
Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …
Read More »A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?
A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …
Read More »Digital Diabetes Coaching: Why an App Alone Isn’t Enough
A diabetes app can track meals, count steps, log glucose, and deliver reminders. However, can an app actually help someone turn all that information into lasting daily habits? A recent randomized controlled trial suggests that digital diabetes coaching, with technology supported by ongoing human guidance, may help bridge that gap. …
Read More »More Dietary Fat, Worse Blood Fats? A Low-Carb Diabetes Trial Challenges the Assumption
Does eating more fat automatically mean that more harmful fatty acids will circulate in the blood? A new randomized trial suggests the answer may be more complicated. Researchers studying a low-carb diet for type 2 diabetes found that six months of carbohydrate restriction changed circulating fatty acids in potentially favorable …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.